摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-phenyl-2-(triphenyl-λ5-phosphanylideneamino)pyrrolo[3,4-d][1,2,3]triazole-4,6(2H,5H)-dione | 3929-17-7

中文名称
——
中文别名
——
英文名称
5-phenyl-2-(triphenyl-λ5-phosphanylideneamino)pyrrolo[3,4-d][1,2,3]triazole-4,6(2H,5H)-dione
英文别名
N-Phenyl-2-triphenylphosphoranylidenamino-2H-1,2,3-triazol-dicarboximid;5-phenyl-2-(triphenyl-λ5-phosphanylideneamino)-2H-pyrrolo[4,5-d][1,2,3]triazole-4,6-dione
5-phenyl-2-(triphenyl-λ<sup>5</sup>-phosphanylideneamino)pyrrolo[3,4-d][1,2,3]triazole-4,6(2H,5H)-dione化学式
CAS
3929-17-7
化学式
C28H20N5O2P
mdl
——
分子量
489.473
InChiKey
FQXKOFLUIPSZOR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    213.0-214.5 °C
  • 沸点:
    699.9±65.0 °C(Predicted)
  • 密度:
    1.313 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    4.02
  • 重原子数:
    36.0
  • 可旋转键数:
    5.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    80.45
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    5-phenyl-2-(triphenyl-λ5-phosphanylideneamino)pyrrolo[3,4-d][1,2,3]triazole-4,6(2H,5H)-dione盐酸 作用下, 以 为溶剂, 反应 48.0h, 生成 2-amino-5-phenylpyrrolo[3,4-d]triazole-4,6-dione
    参考文献:
    名称:
    Syntheses and structures of N-phenylmaleimidetriazoles and by-products
    摘要:
    N-苯基马来酰亚胺三唑衍生物的合成、性质和结构进行了描述。还讨论了中间体和副产品。1b. a = 43.997(7) Å,5.7610(9) Å,8.245(1) Å,β = 99.339(4)°,C2/c;2a. a = 13.646(4) Å,b = 7.744(2) Å,c = 10.612(3) Å,β = 91.979(6)°,P21/c。3a. a = 22.245(1) Å,b = 22.245(1) Å,10.010(1) Å,P42/n。3a′. a = 11.727(2) Å,b = 14.075(3) Å,c = 16.080(3) Å,α = 105.859(3)°,β = 105.331(3)°,γ = 98.187(3)°,P-1。3b. a = 8.561(3) Å,b = 14.755(5) Å,c = 22.771(7) Å,β = 97.006(5)°,P21/c。3c. a = 10.500(2) Å,b = 12.189(2) Å,c = 13.040(2) Å,α = 109.091(3)°,β = 106.089(3)°,γ = 101.022(3)°,P-1。8a. a = 16.389(8) Å,b = 5.749(3) Å,c = 19.316(3) Å,β = 97.467(9)°,P21/n。8b. a = 5.822(2) Å,b = 10.114(3) Å,c = 16.705(4) Å,α = 84.681(5)°,β = 82.840(5)°,γ = 75.769(4)°,P-1。9b. a = 11.251(1) Å,13.335(3) Å,13.376(3) Å,β = 102.456(4)°,P21/n。9c. a = 15.836(3) Å,b = 8.236(2) Å,c = 5.447(3) Å,β = 92.551(3)°,P21/c。10a. a = 13.177(2) Å,b = 14.597(2) Å,c = 5.5505(8) Å,β = 110.979(2)°,Cc。11a. a = 14.720(2) Å,b = 13.995(2) Å,c = 38.245(6) Å,β = 94.430(3)°,P21/n。12b. a = 15.067(5) Å,b = 20.378(6) Å,c = 8.669(5) Å,α = 99.16(4)°,β = 99.32(3)°,γ = 105.23(3)°,P-1。13b. a = 8.2824(6) Å,b = 10.5245(7) Å,c = 15.518(1) Å,α = 92.305(1)°,β = 100.473(1)°,γ = 100.124(1)°,P-1。15a. a = 15.357(3) Å,b = 7.778(2) Å,c = 22.957(2) Å,Pbca。16b. a = 18.0384(4) Å,b = 12.474(3) Å,c = 20.078(5) Å,Pbca。
    DOI:
    10.1007/s10870-005-1693-y
  • 作为产物:
    参考文献:
    名称:
    Syntheses and structures of N-phenylmaleimidetriazoles and by-products
    摘要:
    N-苯基马来酰亚胺三唑衍生物的合成、性质和结构进行了描述。还讨论了中间体和副产品。1b. a = 43.997(7) Å,5.7610(9) Å,8.245(1) Å,β = 99.339(4)°,C2/c;2a. a = 13.646(4) Å,b = 7.744(2) Å,c = 10.612(3) Å,β = 91.979(6)°,P21/c。3a. a = 22.245(1) Å,b = 22.245(1) Å,10.010(1) Å,P42/n。3a′. a = 11.727(2) Å,b = 14.075(3) Å,c = 16.080(3) Å,α = 105.859(3)°,β = 105.331(3)°,γ = 98.187(3)°,P-1。3b. a = 8.561(3) Å,b = 14.755(5) Å,c = 22.771(7) Å,β = 97.006(5)°,P21/c。3c. a = 10.500(2) Å,b = 12.189(2) Å,c = 13.040(2) Å,α = 109.091(3)°,β = 106.089(3)°,γ = 101.022(3)°,P-1。8a. a = 16.389(8) Å,b = 5.749(3) Å,c = 19.316(3) Å,β = 97.467(9)°,P21/n。8b. a = 5.822(2) Å,b = 10.114(3) Å,c = 16.705(4) Å,α = 84.681(5)°,β = 82.840(5)°,γ = 75.769(4)°,P-1。9b. a = 11.251(1) Å,13.335(3) Å,13.376(3) Å,β = 102.456(4)°,P21/n。9c. a = 15.836(3) Å,b = 8.236(2) Å,c = 5.447(3) Å,β = 92.551(3)°,P21/c。10a. a = 13.177(2) Å,b = 14.597(2) Å,c = 5.5505(8) Å,β = 110.979(2)°,Cc。11a. a = 14.720(2) Å,b = 13.995(2) Å,c = 38.245(6) Å,β = 94.430(3)°,P21/n。12b. a = 15.067(5) Å,b = 20.378(6) Å,c = 8.669(5) Å,α = 99.16(4)°,β = 99.32(3)°,γ = 105.23(3)°,P-1。13b. a = 8.2824(6) Å,b = 10.5245(7) Å,c = 15.518(1) Å,α = 92.305(1)°,β = 100.473(1)°,γ = 100.124(1)°,P-1。15a. a = 15.357(3) Å,b = 7.778(2) Å,c = 22.957(2) Å,Pbca。16b. a = 18.0384(4) Å,b = 12.474(3) Å,c = 20.078(5) Å,Pbca。
    DOI:
    10.1007/s10870-005-1693-y
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫